KLK3 and posterior cortical atrophy: Moreover, the performance of the biomarker panel indicated that in the current study cohort (n = 777 patients), 130 (43%) patients without PCa would not be recommended for biopsy, reducing the number of unnecessary biopsies compared to all 300 patients with PSA alone who would have been recommended for a biopsy.